Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_assertion type Assertion NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_head.
- NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_assertion wasGeneratedBy ECO_0000203 NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_provenance.
- NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_assertion wasDerivedFrom lhgdn-20090331 NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_provenance.
- NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_assertion SIO_000772 19028704 NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_provenance.
- NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_assertion evidence source_evidence_literature NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_provenance.
- NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_provenance.